The genetically modified potato lines show a shift of the tuber
starch composition to amylopectin. No difference regarding
persistence in agricultural habitats or invasiveness in natural
habitats compared to conventional potato varieties is expected. Nor
is it expected that a selective advantage or disadvantage is
conferred to the GM lines via the introduced traits. Due to the
measures to be taken during the release (distance to or absence of
cultivated and wild relatives) will the potential for gene transfer
virtually be excluded. Interactions of the GM potato lines with
non-target species and resulting effects will be comparable to
those of conventional potato varieties. No toxic or allergenic
effects are expected from elevated levels of amylopectin, nor from
the acetohydroxyacid synthase or neomycin phosphotransferase II.
Measures in place under current field trial practice will protect
the trial from damage by animals as well as safeguard that all seed
and plant material is properly managed, harvested, stored,
transported or disposed of to minimize or prevent contact to humans
or animals. No effects are expected on biogeochemical processes.
The GM potato lines will be cultivated under conventional
See the attachment for details.